Fertility treatment in women with premature ovarian failure

Expert Review of Obstetrics and Gynecology

Volumn 6, Issue 3, 2011, Pages 321-330

  Blumenfeld, Zeev ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

fertility treatment; GnRH agonist; gonadotoxicity; hypergonadotropic amenorrhea; POF

Indexed keywords

ACETYLSALICYLIC ACID; AROMATASE INHIBITOR; CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN RECEPTOR; GESTAGEN; GLUCOCORTICOID; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; IMMUNOGLOBULIN; MELPHALAN; NITRIC OXIDE; PLACEBO; PRASTERONE; PREDNISONE; PROCARBAZINE; PROGESTERONE; RECOMBINANT GROWTH HORMONE; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN; UNINDEXED DRUG; VINCRISTINE SULFATE;

ADJUVANT THERAPY; AUTOIMMUNE DISEASE; BREAST CANCER; CANCER SURVIVOR; CHEMOTHERAPY; CRYOPRESERVATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG COST; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE FERTILITY; HODGKIN DISEASE; HUMAN; IMMUNOPATHOGENESIS; LOW DRUG DOSE; NONHUMAN; OOCYTE DONATION; OUTCOME ASSESSMENT; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; REVIEW; VASCULITIS;

EID: 79959281620     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.11.15     Document Type: Review

References (57)

1. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr. Rev. 18, 107-134 (1997) (Pubitemid 27076457)
2. Skillern A, Rajkovic A. Recent developments in identifying genetic determinants of premature ovarian failure. Sex. Dev. 2(4-5), 228-243 (2008)
3. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann. NY Acad. Sci. 1135, 146-154 (2008) (Pubitemid 351862133)
4. Goswami D, Conway GS. Premature ovarian failure. Hum. Reprod. Update 11(4), 391-410 (2005) (Pubitemid 40895467)
5. Krauss CM, Turksoy RN, Atkins L, McLaughin C, Brown L, Page DC. Familial premature ovarian failure due to an interstitial deletion of the long arm of the 3 chromosome. N. Engl. J. Med. 317, 125-131 (1987) (Pubitemid 17092148)
6. Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD. 1981 reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 214, 1145-1147 (1981) (Pubitemid 12176630)
7. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum. Reprod. Update 12(5), 573-584 (2006) (Pubitemid 44307834)
8. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum. Reprod. Update 14, 543-552 (2008)
9. Blumenfeld Z. Premature ovarian failure: etiology and possible prevention. Expert Rev. Endocrinol. Metab. 4, 173-181 (2009)
10. Shelling AN. Premature ovarian failure. Reproduction 140(5), 633-641 (2010)
11. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J. Mol. Endocrinol. 45(5), 257-279 (2010)
12. Rebar RW. Premature ovarian failure. Obstet. Gynecol. 113(6), 1355-1363 (2009)
13. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 376(9744), 911-921 (2010)
14. Blumenfeld Z, Halachmi S, Peretz BA et al. Premature ovarian failure - the prognostic application of autoimmunity on conception after ovulation induction. Fertil. Steril. 59, 750-755 (1993) (Pubitemid 23104173)
15. van Kasteren YM, Hoek A, Schoemaker J. Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil. Steril. 64, 273-278 (1995)
16. Badawy A, Goda H, Ragab A. Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reprod. Biomed. Online 15, 215-219 (2007) (Pubitemid 47263331)
17. Merviel P, Lourdel E, Boulard V et al. Premature ovarian failure: which protocols? Gynecol. Obstet. Fertil. 36, 872-881 (2008)
18. Loutradis D, Drakakis P, Vomvolaki E, Antsaklis A. Different ovarian stimulation protocols for women with diminished ovarian reserve. J. Assist. Reprod. Genet. 24, 597-611 (2008)
19. Check JH, Srivastava M, Brasile D, Amui J, Choe JK, Dix E. Successful pregnancy with frozen embryo transfer into a gestational carrier from eggs obtained from a woman in premature menopause. Clin. Exp. Obstet. Gynecol. 36, 154-157 (2009).
20. Check JH. Pharmacological options in resistent ovary syndrome and premature ovarian failure. Clin. Exp. Obstet. Gynecol. 33, 71-77 (2006) (Pubitemid 44204684)
21. Check JH, Katsoff B. Ovulation induction and pregnancy in a woman with premature menopause following gonadotropin suppression with the gonadotropin releasing hormone antagonist, cetrorelix - a case report. Clin. Exp. Obstet. Gynecol. 35, 10-12 (2008) (Pubitemid 351345808)
22. Check JH, Katsoff B. Successful pregnancy with spontaneous ovulation in a woman with apparent premature ovarian failure who failed to conceive despite four transfers of embryos derived from donated oocytes. Clin. Exp. Obstet. Gynecol. 33, 13-15 (2006)
23. Check ML, Check JH, Kaplan H. Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review. Clin. Exp. Obstet. Gynecol. 31, 299-301 (2004) (Pubitemid 40138176)
24. Check JH, Summers D, Nazari A, Choe J. Successful pregnancy following in vitro fertilization-embryo transfer despite imminent ovarian failure. Clin. Exp. Obstet. Gynecol. 27, 97-99 (2000) (Pubitemid 30636274)
25. Check JH, Nowroozi K, Nazari A. Viable pregnancy in a woman with premature ovarian failure treated with gonadotropin suppression and human menopausal gonadotropin stimulation. A case report. J. Reprod. Med. 36, 195-197 (1991)
26. Check JH, Chase JS, Wu CH, Adelson HG. Ovulation induction and pregnancy with an estrogen-gonadotropin stimulation technique in a menopausal woman with marked hypoplastic ovaries. Am. J. Obstet. Gynecol. 160, 405-406 (1989) (Pubitemid 19065385)
27. Check JH, Chase JS, Spence M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. Am. J. Obstet. Gynecol. 160, 114-115 (1989) (Pubitemid 19055270)
28. Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil. Steril. 91, 644-646 (2009)
29. Barbarino-Monnier P. From pathological diagnosis to ovulation induction. The case of ovarian insufficiency. [Article in French]. Gynecol. Obstet. Fertil. 29, 39-48 (2001)
30. Blumenfeld Z. GnRH-agonists in fertility preservation. Curr. Opin. Endocrinol. Diabetes Obes. 15, 523-528 (2008)
31. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011)
32. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Br. J. Obstet. Gynaecol. 109, 107-114 (2002) (Pubitemid 37338030)
33. Sklar CA, Mertens AC, Mitby P et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J. Natl Cancer Inst. 98, 890-896 (2006) (Pubitemid 44018918)
34. van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol. Oncol. 28(4), 168-179 (2010)
35. Donnez J, Jadoul P, Squifflet J et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract. Res. Clin. Obstet. Gynaecol. 24, 87-100 (2010)
36. Dolmans MM, Donnez J, Camboni A et al. IVF outcome in patients with orthotopically transplanted ovarian tissue. Hum. Reprod. 24, 2778-2787 (2009)
37. Kyono K, Doshida M, Toya M, Sato Y, Akahira J, Sasano H. Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. Fertil. Steril. 93, 2429-2430 (2010)
38. Blumenfeld Z. Fertility preservation and GnRH-a for chemotherapy: debate. Arch. Gynecol. Obstet. 282(5), 585-586 (2010)
39. Clowse ME, Behera MA, Anders CK et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J. Womens Health 18(3), 311-319 (2009)
40. Beck-Fruchter R, Weiss A, Shalev E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum. Reprod. Update 14(6), 553-561 (2008)
41. Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil. Steril. 91, 694-697 (2009)
42. Del Mastro L, Boni L, Michelotti A et al. Role of luteinizing hormone-releasing hormone analog (LHRHa) triptorelin (T) in preserving ovarian function during chemotherapy for early breast cancer patients: results of a multicenter Phase III trial of Gruppo Italiano Mammella (GIM) group. J. Clin. Oncol. 28(Suppl. 15), (2010) (Abstract 528)
43. Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res. Treat. 117, 561-567 (2009)
44. Ataya K, Rao LV, Laurence E, Kimmel R. Luteinizing hormone-releasing agonist inhibits cyclophosphamide induced ovarian follicular depletion in Rhesus monkeys. Biol. Reprod. 52, 365-372 (1995)
45. Imai A, Sugiyama M, Furui T, Tamaya T, Ohno T. Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecol. Obstet. Invest. 63, 102-106 (2007)
46. Edgar AB, Wallace WHB. Pregnancy in women who had cancer in childhood. Eur. J. Cancer 43, 1890-1894 (2007) (Pubitemid 47284867)
47. Blumenfeld Z, Avivi I, Eckman A et al. Gonadotropin releasing hormone agonist decreases chemotherapy induced gonadotoxicity and premature ovarian failure in young female patients with hodgkin lymphoma. Fertil. Steril. 89, 166-173 (2008)
48. Moore HCF. Ovarian Failure After Chemotherapy for Breast Cancer and theRole of Gonadotropin-Releasing Hormone Analogs in Protection of Ovarian Function. ASCO Educational Book, Spring, 39-42 (2008)
49. Recchia F, Saggio G, Amiconi G et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106, 514-523 (2006) (Pubitemid 43157613)
50. Del Mastro L, Catzeddu T, Boni L et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young early breast cancer patients. Ann. Oncol. 17, 74-78 (2006) (Pubitemid 43033843)
51. Cuzick J, Ambroisine L, Davidson N et al. LHRH-agonists in early breast cancer overview group. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer: a metαanalysis of individual patient data from randomised adjuvant trials. Lancet 369, 1711-1723 (2007)
52. Sharma R, Hamilton A, Beith J. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Cochrane Database Syst. Rev. 8(4), CD004562 (2008)
53. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 12, 1044-1054 (2007) (Pubitemid 350007016)
54. Blumenfeld Z, Zuckerman T. Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment. Oncologist 15, 59-60 (2010)
55. Remérand G,Merlin E,Froissart R,et al. Four successful pregnancies in a patient with mucopolysaccharidosis type I treated by allogeneic bone marrow transplantation. J. Inherit. Metab. Dis. DOI: 101007/ s10545-009-1095-y (2009) (Epub ahead of print)
56. Salooja N, Szydlo RM, Socie G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358, 271-276 (2001) (Pubitemid 32738965)
57. Carter A, Robison LL, Francisco L et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study. Bone Marrow Transplant. 37, 1023-1029 (2006).